Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
Bangladesh
· Delayed Price · Currency is BDT 13.10
-0.30 (-2.24%)
At close: Mar 5, 2026
DSE:IBP Revenue
Indo-Bangla Pharmaceuticals had revenue of 41.58M BDT in the quarter ending September 30, 2025, with 49.92% growth. This brings the company's revenue in the last twelve months to 198.02M, up 66.30% year-over-year. In the fiscal year ending June 30, 2025, Indo-Bangla Pharmaceuticals had annual revenue of 184.18M with 4.27% growth.
Revenue (ttm)
198.02M
Revenue Growth
+66.30%
P/S Ratio
7.69
Revenue / Employee
1.56M
Employees
127
Market Cap
1.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 184.18M | 7.54M | 4.27% |
| Jun 30, 2024 | 176.64M | -197.84M | -52.83% |
| Jun 30, 2023 | 374.48M | -110.20M | -22.74% |
| Jul 1, 2022 | 484.68M | -297.56M | -38.04% |
| Jul 1, 2021 | 782.24M | -83.86M | -9.68% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharma Aids | 453.49M |
| Libra Infusions | 197.03M |
| Silco Pharmaceuticals | 428.63M |
| Ambee Pharmaceuticals | 193.90M |
| Silva Pharmaceuticals | 356.99M |
| Advent Pharma | 516.48M |
| Central Pharmaceuticals | 33.51M |
| Techno Drugs | 3.15B |